Current Oncology (Nov 2021)

Impact of COVID-19 on Radiation Oncology, an Austrian Experience

  • Julian Mangesius,
  • Christoph Reinhold Arnold,
  • Thomas Seppi,
  • Stephanie Mangesius,
  • Mario Brüggl,
  • Paul Eichberger,
  • Ute Ganswindt

DOI
https://doi.org/10.3390/curroncol28060404
Journal volume & issue
Vol. 28, no. 6
pp. 4776 – 4785

Abstract

Read online

The COVID-19 pandemic has an unprecedented impact on cancer treatment worldwide. We aimed to evaluate the effects of the pandemic on the radiation treatment of patients in order to provide data for future management of such crises. We compared the number of performed radiotherapy sessions of the pandemic period from February 2020 until May 2021 with those of 2018 and 2019 for reference. At our department, no referred patients had to be rejected or postponed, nor any significant changes in fractionation schedules implemented. Nevertheless, there was a substantial drop in overall radiotherapy sessions in 2020 following the first incidence wave of up to −25% (in June) in comparison to previous years. For breast cancer, a maximum decline of sessions of −45% (July) was recorded. Only a short drop of prostate cancer sessions (max −35%, May) followed by a rebound (+42%, July) was observed. Over the investigated period, a loss of 4.4% of expected patients never recovered. The severe impact of COVID-19 on cancer treatment, likely caused by retarded diagnosis and delayed interdisciplinary co-treatment, is reflected in a lower count of radiotherapy sessions. Radiation oncology is a crucial cornerstone in upholding both curative treatment options and treatment capacity during a pandemic.

Keywords